These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 20051606)

  • 21. Neuropathology of Lewy body disorders.
    Kövari E; Horvath J; Bouras C
    Brain Res Bull; 2009 Oct; 80(4-5):203-10. PubMed ID: 19576266
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intralaminar nuclei of the thalamus in Lewy body diseases.
    Brooks D; Halliday GM
    Brain Res Bull; 2009 Feb; 78(2-3):97-104. PubMed ID: 18804518
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Apolipoprotein E epsilon4 and catechol-O-methyltransferase alleles in autopsy-proven Parkinson's disease: relationship to dementia and hallucinations.
    Camicioli R; Rajput A; Rajput M; Reece C; Payami H; Hao C; Rajput A
    Mov Disord; 2005 Aug; 20(8):989-94. PubMed ID: 15852364
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Controversy: is Parkinson's disease a single disease entity? Yes.
    Takahashi H; Wakabayashi K
    Parkinsonism Relat Disord; 2005 Jun; 11 Suppl 1():S31-7. PubMed ID: 15885626
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Olfactory system pathology as a model of Lewy neurodegenerative disease.
    Duda JE
    J Neurol Sci; 2010 Feb; 289(1-2):49-54. PubMed ID: 19783257
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synphilin-1 is present in Lewy bodies in Parkinson's disease.
    Wakabayashi K; Engelender S; Yoshimoto M; Tsuji S; Ross CA; Takahashi H
    Ann Neurol; 2000 Apr; 47(4):521-3. PubMed ID: 10762166
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cognitive status correlates with neuropathologic stage in Parkinson disease.
    Braak H; Rüb U; Jansen Steur EN; Del Tredici K; de Vos RA
    Neurology; 2005 Apr; 64(8):1404-10. PubMed ID: 15851731
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A modern hypothesis: The distinct pathologies of dementia associated with Parkinson's disease versus Alzheimer's disease.
    Farlow MR; Cummings J
    Dement Geriatr Cogn Disord; 2008; 25(4):301-8. PubMed ID: 18311077
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A molecular pathway of neurodegeneration linking alpha-synuclein to ApoE and Abeta peptides.
    Gallardo G; Schlüter OM; Südhof TC
    Nat Neurosci; 2008 Mar; 11(3):301-8. PubMed ID: 18297066
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Do alpha-synuclein aggregates in autonomic plexuses predate Lewy body disorders?: a cohort study.
    Minguez-Castellanos A; Chamorro CE; Escamilla-Sevilla F; Ortega-Moreno A; Rebollo AC; Gomez-Rio M; Concha A; Munoz DG
    Neurology; 2007 Jun; 68(23):2012-8. PubMed ID: 17548551
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Peripheral Lewy body pathology in Parkinson's disease and incidental Lewy body disease: four cases.
    Del Tredici K; Duda JE
    J Neurol Sci; 2011 Nov; 310(1-2):100-6. PubMed ID: 21689832
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The relevance of iron in the pathogenesis of Parkinson's disease.
    Sian-Hülsmann J; Mandel S; Youdim MB; Riederer P
    J Neurochem; 2011 Sep; 118(6):939-57. PubMed ID: 21138437
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A timeline for Parkinson's disease.
    Hawkes CH; Del Tredici K; Braak H
    Parkinsonism Relat Disord; 2010 Feb; 16(2):79-84. PubMed ID: 19846332
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Knowing me, knowing you: can a knowledge of risk factors for Alzheimer's disease prove useful in understanding the pathogenesis of Parkinson's disease?
    Sutherland GT; Siebert GA; Kril JJ; Mellick GD
    J Alzheimers Dis; 2011; 25(3):395-415. PubMed ID: 21441655
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Technology insight: imaging neurodegeneration in Parkinson's disease.
    Brooks DJ
    Nat Clin Pract Neurol; 2008 May; 4(5):267-77. PubMed ID: 18382437
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dynamic modelling of protein and oxidative metabolisms simulates the pathogenesis of Parkinson's disease.
    Cloutier M; Wellstead P
    IET Syst Biol; 2012 Jun; 6(3):65-72. PubMed ID: 22757585
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Brain aging and Parkinson's disease: New therapeutic approaches using drug delivery systems.
    Rodríguez-Nogales C; Garbayo E; Carmona-Abellán MM; Luquin MR; Blanco-Prieto MJ
    Maturitas; 2016 Feb; 84():25-31. PubMed ID: 26653838
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Amine accumulation: a possible precursor of Lewy body formation in Parkinson's disease.
    Sandyk R; Willis GL
    Int J Neurosci; 1992 Sep; 66(1-2):61-74. PubMed ID: 1304571
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The vermiform appendix impacts the risk of developing Parkinson's disease.
    Killinger BA; Madaj Z; Sikora JW; Rey N; Haas AJ; Vepa Y; Lindqvist D; Chen H; Thomas PM; Brundin P; Brundin L; Labrie V
    Sci Transl Med; 2018 Oct; 10(465):. PubMed ID: 30381408
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Parkinson's disease and osteoporosis: basic and clinical implications.
    Figueroa CA; Rosen CJ
    Expert Rev Endocrinol Metab; 2020 May; 15(3):185-193. PubMed ID: 32336178
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.